588
Views
4
CrossRef citations to date
0
Altmetric
Surgery

A post-marketing assessment of major bleeding in total hip and total knee replacement surgery patients receiving rivaroxaban

, , , , , , & show all
Pages 1717-1723 | Received 13 Jan 2017, Accepted 23 May 2017, Published online: 20 Jul 2017

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.